HomeNDC LookupRxCUI directory › RxCUI 310015

Dorzolamide 20 MG/ML Ophthalmic Solution — RxCUI 310015

RxNorm drug concept · Semantic clinical drug
RxCUI 310015 Semantic clinical drug · SCD ● Current RxNorm concept 15 FDA products 16 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310015
Official nameDorzolamide 20 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdorzolamide 2 % Ophthalmic Solution; dorzolamide HCl 2 % Ophthalmic Solution; dorzolamide 20 MG/ML (as dorzolamide HCl 22.3 MG/ML) Ophthalmic Solution
FDA products mapped15
Package NDCs mapped16
Reported Medicaid activity (SDUD)67,286 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dorzolamide Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Your eye constantly makes a fluid that keeps it properly pressurized — but in some people, that pressure gets too high, which can damage the optic nerve over time. Dorzolamide bloc...
  • What exactly does dorzolamide do for my eyes?
  • Yes, that's very common with dorzolamide — about one in four people notice it. Eye drops can drain into the back of your throat through a small channel between your eye and nose, w...
  • I always get a bitter taste after using my eye drops — is that normal?
📖 Read our full Dorzolamide Ophthalmic guide →

🕸️ Concept Web — How Dorzolamide 20 MG/ML Ophthalmic Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dorzolamide 20 MG/ML Ophthalmic Solution RxCUI 310015

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Dorzolamide 60207
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dorzolamide Ophthalmic Solution 377440
    • Dorzolamide Ophthalmic Product 1160644
    • Ophthalmic Solution 7670
    • Ophthalmic Product 1151135
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Dorzolamide 20 MG/ML 328229

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dorzolamide 20 MG/ML SCDC · 328229
  • Dorzolamide Ophthalmic Solution SCDF · 377440
  • Dorzolamide Ophthalmic Product SCDG · 1160644

📦 FDA Products & Package NDCs

15 products · 16 package NDCs
16 package NDCs map to RxCUI 310015 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
14445-0404-10 1 BOTTLE, DISPENSING in 1 CARTON (14445-404-10) / 10 mL in... Dorzolamide Hydrochloride Indoco Remedies Limited 2021-05-14
24208-0485-10 1 BOTTLE, DROPPER in 1 CARTON (24208-485-10) / 10 mL in 1 B... Dorzolamide HCl Bausch & Lomb Incorporated 2009-06-25
25021-0006-10 1 BOTTLE in 1 CARTON (25021-006-10) / 10 mL in 1 BOTTLE Dorzolamide Hydrochloride Sagent Pharmaceuticals 2026-01-15
42571-0141-26 1 BOTTLE in 1 CARTON (42571-141-26) / 10 mL in 1 BOTTLE Dorzolamide Hydrochloride Ophthalmic Solution Micro Labs Limited 2019-11-11
46708-0519-10 1 BOTTLE in 1 CARTON (46708-519-10) / 10 mL in 1 BOTTLE Dorzolamide Hydrochloride Alembic Pharmaceuticals Limited 2019-08-09
50090-2406-00 1 BOTTLE, DROPPER in 1 CARTON (50090-2406-0) / 10 mL in 1 B... Dorzolamide HCl A-S Medication Solutions 2016-05-18
50090-4882-00 1 BOTTLE in 1 CARTON (50090-4882-0) / 10 mL in 1 BOTTLE Dorzolamide Hydrochloride Ophthalmic A-S Medication Solutions 2020-02-11
61314-0019-10 10 mL in 1 BOTTLE (61314-019-10) DORZOLAMIDE HYDROCHLORIDE Sandoz Inc 2009-06-01
62332-0519-10 1 BOTTLE in 1 CARTON (62332-519-10) / 10 mL in 1 BOTTLE Dorzolamide Hydrochloride Alembic Pharmaceuticals Inc. 2019-08-09
68083-0489-01 1 BOTTLE in 1 CARTON (68083-489-01) / 10 mL in 1 BOTTLE Dorzolamide Hydrochloride Gland Pharma Limited 2022-01-27
69315-0304-05 1 BOTTLE in 1 CARTON (69315-304-05) / 5 mL in 1 BOTTLE Dorzolamide hydrochloride Leading Pharma, LLC 2019-12-01
69315-0304-10 1 BOTTLE in 1 CARTON (69315-304-10) / 10 mL in 1 BOTTLE Dorzolamide hydrochloride Leading Pharma, LLC 2019-12-01
70069-0501-01 1 BOTTLE in 1 CARTON (70069-501-01) / 10 mL in 1 BOTTLE Dorzolamide Hydrochloride Somerset Therapeutics, LLC 2025-02-12
71921-0400-10 10 mL in 1 BOTTLE (71921-400-10) Dorzolamide Hydrochloride Ophthalmic Florida Pharmaceutical Products, LLC 2025-05-07
72266-0197-01 1 BOTTLE in 1 CARTON (72266-197-01) / 10 mL in 1 BOTTLE Dorzolamide Hydrochloride FOSUN PHARMA USA INC 2023-01-23
72888-0077-15 1 BOTTLE in 1 CARTON (72888-077-15) / 10 mL in 1 BOTTLE DORZOLAMIDE HYDROCHLORIDE Advagen Pharma Ltd. 2024-12-23
Observed labelers: A-S Medication Solutions (2) · Leading Pharma, LLC (2) · Advagen Pharma Ltd. (1) · Alembic Pharmaceuticals Inc. (1) · Alembic Pharmaceuticals Limited (1) · Bausch & Lomb Incorporated (1) · +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.